- ►publichealth.ru [PDF] D Daneman - The Lancet, 2006 - Elsevier Type 1 diabetes accounts for only about 5–10% of all cases of diabetes;
however, its incidence continues to increase worldwide and it has serious
short-term and long-term implications. The disorder has a strong genetic ... Cited by 125 - Related articles - All 27 versions
- ►ecmaj.ca AYY Cheng, IG Fantus - Canadian Medical Association Journal, 2005 - ecmaj.ca DIABETES MELLITUS IS A CHRONIC DISEASE that is growing in prevalence worldwide.
Pharmacologic therapy is often necessary to achieve optimal glycemic control in
the management of diabetes. Orally administered antihyperglycemic agents ... Cited by 71 - Related articles - All 16 versions
SM Strowig, P Raskin - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—Both groups experienced a significant reduction in HbA 1c (A1C) level
(rosiglitazone: 7.9 ± 1.3 to 6.9 ± 0.7%, P < 0.0001; placebo: 7.7 ± 0.8 to
7.0 ± 0.9%, P = 0.002) and a significant increase in weight ... Cited by 25 - Related articles - BL Direct - All 6 versions
SM Strowig, P Raskin - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com The biguanide, metformin, sensitizes the liver to the effect of insulin,
suppressing hepatic glucose output. Thiazolidinediones such as rosiglitazone and
pioglitazone enhance insulin-mediated glucose disposal, leading to reduced ... Cited by 20 - Related articles - BL Direct - All 5 versions
AS Khan, CR McLoughney, AB Ahmed - DIABETIC MEDICINE-CHICHESTER-, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 5 versions
JA Altschuler, SJ Casella, TA MacKenzie, KM … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Using a prospective, double-blind,
placebo-controlled design, 72 adolescent type 1 diabetic subjects were treated
in an outpatient setting with cinnamon (1 g/day) or an equivalent-appearing ... Cited by 13 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] JD Faichney, PW Tate - Diabetes care, 2003 - Am Diabetes Assoc Our objective was to evaluate the di- agnostic proficiency of the World Health
Organization (WHO) and the National Cholesterol Education Pro- gram (NCEP)-III
definitions (1,2) for the metabolic syndrome in a Mexican nation- wide, ... Cited by 4 - Related articles - BL Direct - All 5 versions
SS Lund, L Tarnow, AS Astrup, P Hovind, PK … - PLoS ONE, 2008 - pubmedcentral.nih.gov Methodology/Principal Findings: One hundred patients with T1DM, preserved
hypoglycaemic awareness and HaemoglobinA1c (HbA1c) $8.5% during the year before
enrolment entered a one-month run-in on placebo treatment. Thereafter, ... Cited by 4 - Related articles - All 9 versions
- ►nursing2008.com TTL Pang, P Narendran - Diabetic Medicine, 2008 - pt.wkhealth.com Type 1 diabetes is recognised to include an element of insulin resistance.
Insulin resistance is an independent risk factor for the development of macro-
and microvascular complications of Type 1 diabetes and may also contribute ... Cited by 4 - Related articles - All 5 versions
- ►diabetesjournals.org [PDF] L Meyer, B Guerci - Diabetes Care, 2003 - Am Diabetes Assoc Our objective was to evaluate the di- agnostic proficiency of the World Health
Organization (WHO) and the National Cholesterol Education Pro- gram (NCEP)-III
definitions (1,2) for the metabolic syndrome in a Mexican nation- wide, ... Cited by 3 - Related articles - BL Direct - All 4 versions
